Reports

Sale

United States Diagnostics Market

United States Diagnostics Market Size, Share, Trends, Report: By Product Type: Reagents, Instruments, Software and Services; By Technique: Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others; By Usage; By Applications; By End User; Patent Analysis; Supplier Landscape; 2024-2032

United States Diagnostics Market Outlook

The United States diagnostics market size is anticipated to grow at a CAGR of 5.17% during the forecast period of 2024-2032 driven by the rising awareness among people about healthy lifestyle.

 

Diagnostics: Introduction

When a disease or condition is checked or analyzed by a healthcare professional, it is generally termed as diagnosing the condition, where diagnostics refers to the processes that are used to conclude the outcome on that analysis. With the help of diagnostic tests several diseases and medical conditions are detected and treated with the right treatment approach when diagnosed.

 

By detecting a disease on time, it becomes easy to treat it on time as it helps in knowing details about the disease like how fatal or normal a condition is and what are the measure that a patient can take to prevent it in future.

 

United States Diagnostics Market Analysis

There are several key trends justifying the growth of the market, including the increasing involvement of advanced technologies in the diagnostics field, such as risk analysis and pattern recognition, among others. The increasing demand for point-of-care testing POCT has also been driving the market growth.

 

Additionally, the development of easy-to-use diagnostics devices is also acting as a trend and has been aiding the United States diagnostics market expansion. Due to the increasing and advancing use of technologies like polymerase chain reaction (PCR), next-generation sequencing (NGS), and personalized diagnostic testing, the market is expected to witness significant growth. The increasing integration of smart technologies such as artificial intelligence (AI) and machine learning (ML) in the diagnostic field of healthcare is expected to revolutionize the market.

 

The arrival of Digital pathology (DP) in the market is a great action and is significantly aiding the United States diagnostics market development. Digital pathology offers several benefits and has an extended scope of applications. These benefits include easy sharing features with which sharing of slides worldwide is just as simple as sending documents with smartphone.

 

United States Diagnostics Market Segmentations

Market Breakup by Product Type

  • Reagents
  • Instruments
  • Software and Services

 

Market Breakup by Technique

  • Immunodiagnostics 
  • Clinical Techniques 
  • Molecular Diagnostics 
  • Tissue Diagnostics  
  • Others

 

Market Breakup by Usage

  • Disposable 
  • Reusables

 

Market Breakup by Applications

  • Infectious Diseases  
    • Human Papillomavirus 
    • Hepatitis 
    • Tuberculosis 
    • Hospital-Acquired Infections 
    • COVID-19 
    • Others 
  • Cancer  
    • Breast Cancer 
    • Lung Cancer 
    • Colorectal Cancer 
    • Melanoma 
    • Liver Cancer 
    • Others 
  • Sexually Transmitted Diseases 
    • Chlamydia Trachomatis Infection 
    • Gonorrhoea 
    • Syphilis 
    • Others

Market Breakup by End User

  • Hospitals 
  • Public labs  
  • Diagnostic Centers 
  • Point-of-Care Testing Centers 
  • Private or Commercial Laboratories 
  • Others

 

United States Diagnostics Market Overview

United States is the largest diagnostics market globally owing to factors like the rising awareness among people about healthy lifestyle and taking their healthcare serious. The increasing geriatric population, along with multiple diseases in this age, are also a major driver for the United States diagnostics market growth.

 

Additionally, being the largest market across the globe, the high development rate with advanced technologies to improve the quality and performance of the diagnostic methods and equipment is also a major driver for the market. The increasing emphasis on consuming personalized medicines that involves tailoring medical treatments in accordance to the individual patients' unique characteristics, has significantly increased the demand for advanced diagnostic tests. Molecular diagnostics and genetic testing are critical components of personalized medicine that makes the existence of targeted therapies and precise treatment decisions possible and reliable.

 

Due to the high healthcare expenditure per capita, driven by factors such as increased healthcare access, insurance coverage, and a focus on quality healthcare delivery, the demand for diagnostics services is on a rise. This is directly linked to healthcare expenditure because accurate and timely diagnosis is fundamental to effective healthcare delivery and cost management.

 

United States Diagnostics Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Abbott Laboratories, Inc. 
  • Danaher Corporation 
  • Thermo Fisher Scientific, Inc. 
  • Johnson & Johnson 
  • Ortho-Clinical Diagnostics, Inc. 
  • Becton, Dickinson, and Company 
  • Bio-Rad Laboratories, Inc. 
  • Roche Diagnostics Corporation 
  • Siemens Medical Solutions USA, Inc. 
  • Biomerieux Inc.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technique
  • Usage
  • Applications
  • End User
Breakup by Product Type
  • Reagents
  • Instruments
  • Software and Services
Breakup by Technique
  • Immunodiagnostics 
  • Clinical Techniques 
  • Molecular Diagnostics 
  • Tissue Diagnostics  
  • Others
Breakup by Usage
  • Disposable 
  • Reusables
Breakup by Applications
  • Infectious Diseases
  • Cancer
  • Sexually Transmitted Diseases
Breakup by End User
  • Hospitals 
  • Public labs  
  • Diagnostic Centers 
  • Point-of-Care Testing Centers 
  • Private or Commercial Laboratories 
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott Laboratories, Inc. 
  • Danaher Corporation 
  • Thermo Fisher Scientific, Inc. 
  • Johnson & Johnson 
  • Ortho-Clinical Diagnostics, Inc. 
  • Becton, Dickinson, and Company 
  • Bio-Rad Laboratories, Inc. 
  • Roche Diagnostics Corporation 
  • Siemens Medical Solutions USA, Inc. 
  • Biomerieux Inc.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3     United States Diagnostics Market Overview
 
    3.1     United States Diagnostics Market Historical Value (2017-2023) 
    3.2     United States Diagnostics Market Forecast Value (2024-2032)
4     United States Diagnostics Market Landscape
    4.1     United States Diagnostics Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2     United States Diagnostics Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5     United States Diagnostics Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6     United States Diagnostics Market Segmentation 
    6.1     United States Diagnostics Market by Product Type
        6.1.1    Market Overview
        6.1.2    Reagents
        6.1.3    Instruments
        6.1.4    Software and Services 
    6.2    United States Diagnostics Market by Technique
        6.2.1    Market Overview
        6.2.2    Immunodiagnostics
        6.2.3    Clinical Techniques
        6.2.4    Molecular Diagnostics
        6.2.5    Tissue Diagnostics 
        6.2.6    Others
    6.3    United States Diagnostics Market by Usage
        6.3.1    Market Overview
        6.3.2    Disposable
        6.3.3    Reusables
    6.4     United States Diagnostics Market by Applications
        6.4.1    Market Overview
        6.4.2    Infectious Diseases 
            6.4.2.1    Human Papillomavirus
            6.4.2.2    Hepatitis
            6.4.2.3    Tuberculosis
            6.4.2.4    Hospital-Acquired Infections
            6.4.2.5    COVID-19
            6.4.2.6    Others
        6.4.3    Cancer 
            6.4.3.1    Breast Cancer
            6.4.3.2    Lung Cancer
            6.4.3.3    Colorectal Cancer
            6.4.3.4    Melanoma
            6.4.3.5    Liver Cancer
            6.4.3.6    Others
        6.4.4    Sexually Transmitted Diseases
            6.4.4.1    Chlamydia Trachomatis Infection
            6.4.4.2    Gonorrhoea
            6.4.4.3    Syphilis
            6.4.4.4     Others
            6.4.4.5    Others
    6.5    United States Diagnostics Market by End User
        6.5.1    Market Overview
        6.5.2    Hospitals
        6.5.3    Public labs 
        6.5.4    Diagnostic Centers
        6.5.5    Point-of-Care Testing Centers
        6.5.6    Private or Commercial Laboratories
        6.5.7    Others
7    Patent Analysis
    7.1    Analysis by Type of Patent
    7.2    Analysis by Publication year
    7.3    Analysis by Issuing Authority
    7.4    Analysis by Patent Age
    7.5    Analysis by CPC Analysis
    7.6    Analysis by Patent Valuation 
    7.7    Analysis by Key Players
8    Grants Analysis
    8.1    Analysis by year
    8.2    Analysis by Amount Awarded
    8.3    Analysis by Issuing Authority
    8.4    Analysis by Grant Application
    8.5    Analysis by Funding Institute
    8.6    Analysis by NIH Departments
    8.7    Analysis by Recipient Organization 
9    Funding Analysis
    9.1    Analysis by Funding Instances
    9.2    Analysis by Type of Funding
    9.3    Analysis by Funding Amount
    9.4    Analysis by Leading Players
    9.5    Analysis by Leading Investors
    9.6    Analysis by Geography
10    Partnership and Collaborations Analysis
    10.1    Analysis by Partnership Instances
    10.2    Analysis by Type of Partnership
    10.3    Analysis by Leading Players
    10.4    Analysis by Geography
11    Regulatory Framework
    11.1    Regulatory Overview
        11.1.1    US FDA
        11.1.2    EU EMA
        11.1.3    INDIA CDSCO
        11.1.4    JAPAN PMDA
        11.1.5    Others
12    Supplier Landscape
    12.1    Abbott Laboratories, Inc.
        12.1.1    Financial Analysis
        12.1.2    Product Portfolio
        12.1.3    Demographic Reach and Achievements
        12.1.4    Mergers and Acquisitions
        12.1.5    Certifications
    12.2    Danaher Corporation
        12.2.1    Financial Analysis
        12.2.2    Product Portfolio
        12.2.3    Demographic Reach and Achievements
        12.2.4    Mergers and Acquisitions
        12.2.5    Certifications
    12.3    Thermo Fisher Scientific, Inc.
        12.3.1    Financial Analysis
        12.3.2    Product Portfolio
        12.3.3    Demographic Reach and Achievements
        12.3.4    Mergers and Acquisitions
        12.3.5    Certifications
    12.4    Johnson & Johnson
        12.4.1    Financial Analysis
        12.4.2    Product Portfolio
        12.4.3    Demographic Reach and Achievements
        12.4.4    Mergers and Acquisitions
        12.4.5    Certifications
    12.5    Ortho-Clinical Diagnostics, Inc.
        12.5.1    Financial Analysis
        12.5.2    Product Portfolio
        12.5.3    Demographic Reach and Achievements
        12.5.4    Mergers and Acquisitions
        12.5.5    Certifications
    12.6    Becton, Dickinson, and Company
        12.6.1    Financial Analysis
        12.6.2    Product Portfolio
        12.6.3    Demographic Reach and Achievements
        12.6.4    Mergers and Acquisitions
        12.6.5    Certifications
    12.7    Bio-Rad Laboratories, Inc.
        12.7.1    Financial Analysis
        12.7.2    Product Portfolio
        12.7.3    Demographic Reach and Achievements
        12.7.4    Mergers and Acquisitions
        12.7.5    Certifications
    12.8    Roche Diagnostics Corporation
        12.8.1    Financial Analysis
        12.8.2    Product Portfolio
        12.8.3    Demographic Reach and Achievements
        12.8.4    Mergers and Acquisitions
        12.8.5    Certifications
    12.9    Siemens Medical Solutions USA, Inc.
        12.9.1    Financial Analysis
        12.9.2    Product Portfolio
        12.9.3    Demographic Reach and Achievements
        12.9.4    Mergers and Acquisitions
        12.9.5    Certifications
    12.10    Biomerieux Inc.
        12.10.1    Financial Analysis
        12.10.2    Product Portfolio
        12.10.3    Demographic Reach and Achievements
        12.10.4    Mergers and Acquisitions
        12.10.5    Certifications
13    United States Diagnostics Market - Distribution Model (Additional Insight)
    13.1    Overview 
    13.2    Potential Distributors 
    13.3    Key Parameters for Distribution Partner Assessment 
14    Key Opinion Leaders (KOL) Insights (Additional Insight)
15    Company Competitiveness Analysis (Additional Insight)

    15.1    Very Small Companies
    15.2    Small Companies
    15.3    Mid-Sized Companies
    15.4    Large Companies
    15.5    Very Large Companies
16    Payment Methods (Additional Insight)
    16.1    Government Funded
    16.2    Private Insurance
    16.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 5.17% during the forecast period of 2024-2032.

The key drivers for the market growth include the rising prevalence of various disorders and ailments, along with the rising awareness among people about healthy lifestyle.

The different product types in the market are reagents, instruments, software, and services.

The different techniques in the market are immunodiagnostics, clinical techniques, molecular diagnostics, and tissue diagnostics, among others.

It finds wide application in infectious diseases, cancer, and sexually transmitted diseases.

The different end users in the market include hospitals, public labs, diagnostic centers, point-of-care testing centers, private or commercial laboratories, among others.

The increasing demand for point-of-care testing POCT is among the major trends in the market.

Key players involved in the market are Abbott Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Roche Diagnostics Corporation, Inc., Biomerieux Inc., and Siemens Medical Solutions USA.

Purchase Full Report

Mini Report

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER